X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

What are REMS? These extra steps are helping protect patient health

By Bill Chin, M.D.  |    October 6, 2016
As a physician and chief medical officer at PhRMA, I know how important it is to ensure that patients have access to safe, innovative medicines to help them live longer, healthier lives. But...   Read More

What you need to know about PDUFA VI

By Andrew Powaleny  |    July 27, 2016
The U.S. Food and Drug Administration (FDA) recently released its performance goals letter for the sixth installment of the Prescription Drug User Fee Act (PDUFA). The letter comes after months of...   Read More

Dangers of drug importation: A case of counterfeit cancer drugs

By Holly Campbell  |    April 7, 2016
Counterfeit drug trafficking is a multibillion dollar business that threatens the health and well-being of patients. The World Health Organization estimates 10 percent of medicines worldwide are...   Read More

MyOldMeds campaign launches in Massachusetts

By Priscilla VanderVeer  |    February 25, 2016
Every day in Massachusetts, four people die from an opioid overdose. It is one of the most difficult public health challenges facing the Commonwealth, and the country. Prescription drug abuse...   Read More

Policies to combat prescription drug abuse and misuse

By Priscilla VanderVeer  |    December 15, 2015
There has been a lot of discussion recently about prescription drug abuse, and rightfully so. Each day, almost 7,000 people are treated in emergency departments for using prescription opioid drugs...   Read More

Improving PDMPs: Strengthening state tools to prevent prescription drug abuse

By Guest Contributor  |    December 2, 2015
The problem of prescription drug abuse is complex and multi-faceted, and addressing the issue requires a multi-pronged, sustained approach involving a broad range of stakeholders. PhRMA and its...   Read More

National Drug Take Back Day

By Priscilla VanderVeer  |    September 24, 2015
The biopharmaceutical industry believes that any community-driven drug disposal program should involve local law enforcement and be structured to prevent drug abuse and diversion. This Saturday,...   Read More

Upcoming Forum on Improving Critical Tools for Preventing Prescription Drug Abuse

By Anne McDonald Pritchett, PhD  |    June 1, 2015
On June 2, the Network for Excellence in Health Innovation (NEHI) will bring experts from across the country to Boston to discuss a critical public health challenge—the abuse of prescription...   Read More

Teen ODs on Drugs purchased online without Prescription

By PhRMA Staff  |    February 25, 2011
Last week, I wrote about the worldwide counterfeit medicine threat and the dangers that an open U.S. drug supply system poses to patient health and safety. Consumers need to be very careful because...   Read More

A Renewed Commitment To Safety

By PhRMA Staff  |    February 24, 2011
Last year, a high-profile theft of many millions of dollars worth of prescription medicines added a dose of a drama to the biopharmaceutical sector - one that we'd like to avoid. Unfortunately, that...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates